GOSS - Gossamer Bio GAAP EPS of -$0.52 beats by $0.02 May, 09 2023 05:33 PM Gossamer Bio Inc. 2023-05-09 17:33:27 ET Gossamer Bio press release ( NASDAQ: GOSS ): Q1 GAAP EPS of -$0.52 beats by $0.02 . $202 million in cash, cash equivalents & marketable securities, as of March 31, 2023 - For further details see: Gossamer Bio GAAP EPS of -$0.52 beats by $0.02